NEW MJ NEWS

Cresco Labs Launches Adult-Use Cannabis Distribution and Retail Sales in Ohio

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the launch of adult-use distribution and retail sales in the Ohio market. The Company’s Yellow Springs cultivation/processing facility and all five of their Sunnyside Dispensaries have been approved to service both medical and adult-use customers in the state.

“The acceptance of cannabis continues to grow with Ohio becoming the 24th state to launch an adult-use cannabis program. This is a tipping point with almost half of all states allowing adult-use cannabis and more adopting common-sense regulations every day,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “Our Ohio team is ready to welcome new customers to our incredibly popular Sunnyside stores, which are twice as productive as the state average, and introduce them to our award-winning portfolio of branded products.”

The Company manufactures and distributes its Cresco, Supply, Good News, Wonder Wellness, and Mindy’s branded products throughout the state. Sunnyside operates five stores located in Cincinnati, Newark, Chillicothe, Marion and Wintersville. The Company has the right and intends to open three more dispensaries in Ohio, pending approval from the Ohio Department of Commerce.

Ohio is the seventh-most-populous state in the country with nearly three-quarters of Ohioans older than 21. When Ohio reaches its full potential, it is expected to be a $2 billion market a 4x increase from the roughly $0.5 billion in 2023.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240806901201/en/

Contacts

Media
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
312-953-2767

Investors
TJ Cole, Cresco Labs
SVP, Corporate Development & Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

General Cannabis Corp. (CANN) Eyes California Market, Analysts Target, and Financial Review

General Cannabis Eyes California Market, Analysts Target, and Financial Review  Traders News…

$ERBB Announces Marketing Videos

American Green Premieres Marketing Videos Company Offers 20% Off in Store for Holiday…

Cresco Labs (CRLBF) Announces Voting Results of Its Annual Meeting of Shareholders

Cresco Labs Announces Voting Results of Its Annual Meeting of Shareholders Cresco…

Tetra Bio-Pharma Inc. (TBPMF) Provides Update on its Commercialization Plan

Tetra Bio-Pharma Provides Update on its Commercialization Plan for its OTC DIN…